scispace - formally typeset
I

Isabel Van Audenhove

Researcher at Ghent University

Publications -  12
Citations -  1209

Isabel Van Audenhove is an academic researcher from Ghent University. The author has contributed to research in topics: Invadopodia & Cortactin. The author has an hindex of 10, co-authored 11 publications receiving 912 citations.

Papers
More filters
Journal ArticleDOI

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

Jan Van Deun, +101 more
- 01 Mar 2017 - 
TL;DR: It is argued that the field of extracellular vesicle (EV) biology needs more transparent reporting to facilitate interpretation and replication of experiments and EV-TRACK, a crowdsourcing knowledgebase that centralizes EV biology and methodology, is described.
Journal ArticleDOI

Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.

TL;DR: Nanobodies are highly adaptable tools for cancer research as they enable specific modulation of targets, enzymatic and non-enzymatic proteins alike and are endowed with considerable therapeutic potential as inhibitors of receptor-ligand pairs and deliverers of drugs or drug-loaded nanoparticles towards tumors.
Journal ArticleDOI

Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization

TL;DR: It is demonstrated that nanobodies enable high resolution protein function mapping in cells and are shown to be important for formation of properly organized invadopodia, MMP‐9 secretion, matrix degradation, and cancer cell invasion.
Journal ArticleDOI

Fascin Rigidity and L-plastin Flexibility Cooperate in Cancer Cell Invadopodia and Filopodia

TL;DR: By means of specific, high-affinity nanobodies inhibiting bundling of fascin or L-plastin, the cooperative mode of action of these bundlers is unraveled and it is shown that the bundlers cannot compensate for each other due to strikingly different bundling characteristics.
Journal ArticleDOI

Mapping cytoskeletal protein function in cells by means of nanobodies.

TL;DR: As nanobodies can traverse the plasma membrane of eukaryotic cells by means of the enteropathogenic E. coli type III protein secretion system, it is shown that in this promising way of nanobody delivery, actin pedestal formation can be affected following nanobODY injection.